V
VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
HKEX:1873
Price:
0.81 HKD
2.53%
Market Closed
Updated:
May 20, 2024
VIVA Biotech Holdings
Research & Development
|
VIVA Biotech Holdings
Research & Development Peer Comparison
Comparables:
603259
300759
2269
300347
1548
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Research & Development
-¥128m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Research & Development
-¥465m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Research & Development
-¥785.8m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Research & Development
-¥260.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Research & Development
-$432.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Research & Development?
Research & Development
-128m
CNY
-128m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Research & Development amounts to -128m CNY.
What is VIVA Biotech Holdings's Research & Development growth rate?
Research & Development CAGR 5Y
-38%
-38%
Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for VIVA Biotech Holdings have been -25% over the past three years , -38% over the past five years .
You don't have any saved screeners yet
